With medical visits picking up again among patients vaccinated against covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments. This story also… Read More »From Rotten Teeth to Advanced Cancer, Patients Feel the Effects of Treatment Delays
Medical payments platform Inbox Health raised $15 million in series A funding. The company works with third-party billing companies to better communicate with patients and make bills clearer.
IQVIA has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture the two companies formed in 2015. But Quest will remain a preferred provider of lab testing services under an agreement with Q2.
Melinta Therapeutics already sells an antibiotic for serious skin infections. But FDA approval of Kimyrsa gives clinicians another option to offer patients, one with more convenient dosing.
With covid vaccines expected to remain scarce into early spring, Connecticut has scrapped its complicated plans to prioritize immunizations for people under 65 with certain chronic conditions and front-line workers. Instead, the state will primarily base eligibility on age. Gov. Ned Lamont pointed to statistics… Read More »Connecticut Is Doling Out Vaccines Based Strictly on Age. It’s Simpler, but Is it Fair?
Stamford Health has partnered with city and state officials and community organizations to execute its Covid-19 vaccine administration plans. The health system has ambitious plans to vaccinate 3,000 people a day, with a focus on health equity.
Use Our Content It can be republished for free. Dr. Monte Junker, an Oregon dentist, is waiting for his turn to get vaccinated for covid even though he considers himself a front-line health worker. “If they offered it to me today, I would be there,”… Read More »Geography Is Destiny: Dentists’ Access to Covid Shots Depends on Where They Live
In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that would fund efforts to curb opioid abuse and give away drugs to prevent overdose deaths.